Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia - Wikidata - awgldk - TriplyDB

Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia

Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia

http://www.wikidata.org/entity/Q34121336

about

Epigenetic dysregulation of NKD2 is a valuable predictor assessing treatment outcome in acute myeloid leukemia.Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia

P2860

Q37675993-8E329DAC-A53B-41AA-883C-535C7A45174B Q38695398-19BD95E9-058A-463A-9A1C-AAC44819D38B

P2860

Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia

http://www.wikidata.org/entity/Q34121336

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@ast

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@en

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@nl

type

label

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@ast

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@en

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@nl

prefLabel

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@ast

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@en

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@nl

P1433

Q34121336-37B7F17E-4EC3-40AF-9F2B-7E4BB8F5301B

P1476

Q34121336-F7B52583-0FC7-49C7-8967-20E497E0CC48

P2093

Q34121336-0C11C89C-5439-4AF9-B856-365AE2330BE6

Q34121336-211536F6-49C4-4F46-82C2-17F01CB36FC3

Q34121336-32B7FC37-33FF-4DB4-B4F8-AA7E461501B6

Q34121336-6EC43263-44F2-4A05-ADC2-ADDF123EDDA6

Q34121336-78FAE830-17B4-4D0B-A591-59C3ECA80DC5

Q34121336-8503ED21-0837-43D3-946B-ED38E198767A

Q34121336-8D669605-D051-4AF5-B8C4-9B68A0E3CC2B

Q34121336-9B604D18-CCBE-43C8-92C2-80ACE008E1C2

Q34121336-BFED6BBE-811C-46D9-BC74-5A7757FAE24C

Q34121336-C871A63C-28D4-4B0A-B306-FEE287435A15

P2860

Q34121336-0D3FEF4C-5A6F-46B5-98B4-51D143D1FA30

Q34121336-0E8A88C2-5FE4-4EDA-B063-2A4122C35679

Q34121336-1B5A74FB-BD5A-45BA-8E82-58FBA5831304

Q34121336-2518D7A3-7E5C-4A05-BBA3-03AE68463F0D

Q34121336-3191049E-659A-4315-8286-B36FE3C31594

Q34121336-31C25475-F485-43B5-9D08-E29325ECE66B

Q34121336-361478BA-27DC-426F-B361-BE25C75DABB5

Q34121336-3A52FA5D-EB07-48F1-BE44-5D79F307BC02

Q34121336-47C5DEFE-CBD6-4C37-A28E-A2BC27A904EF

Q34121336-487C3A28-AC4D-4682-9A41-4921D17E684B

P304

Q34121336-A8C6E0F8-0208-496F-A0BF-9060436D336B

P31

Q34121336-29703775-1AE8-4F45-9809-7B224F5F4A7D

P433

Q34121336-70E427CB-9BB5-4B91-976A-680CB636FE74

P478

Q34121336-7A08D354-3E1A-4CE6-9C45-95D00E481B2E

P577

Q34121336-7F06B3AC-7526-435D-9441-00324AF67227

P698

Q34121336-C5A493CF-AB97-4901-8CDF-5A95ADE44A93

P921

Q34121336-52FA151D-DD16-4994-8C10-389282540B2D

Q34121336-FC00B515-9E01-47BB-B459-4F777B09DA0E

P932

Q34121336-155CD309-7D1D-43C9-90DA-47111CFFD1DE

P1433

International Journal of Clinical and Experimental Pathology

P1476

Decreased SFRP2 expression is ...... de novo acute myeloid leukemia

@en

P2093

Chun-Yan Tang

http://www.w3.org/2001/XMLSchema#string

Cui An

http://www.w3.org/2001/XMLSchema#string

Hong Guo

http://www.w3.org/2001/XMLSchema#string

Hong Zhou

http://www.w3.org/2001/XMLSchema#string

Ji-Chun Ma

http://www.w3.org/2001/XMLSchema#string

Jiang Lin

http://www.w3.org/2001/XMLSchema#string

Jing Yang

http://www.w3.org/2001/XMLSchema#string

Jun Qian

http://www.w3.org/2001/XMLSchema#string

Qing Liu

http://www.w3.org/2001/XMLSchema#string

Wei Qian

http://www.w3.org/2001/XMLSchema#string

P2860

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer

Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer

SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

Wnt/β-catenin signaling and disease

Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

The Wnt signaling pathway in development and disease

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

P304

4695-4703

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25197341

http://www.w3.org/2001/XMLSchema#string

P921

P932

4152031

http://www.w3.org/2001/XMLSchema#string